Danimer Historical Financial Ratios

DNMR Stock

USD 6.50 0.50 8.33%

Danimer Scientific is recently reporting on over 100 different financial statement accounts. To analyze all of these accounts together requires a lot of time and effort. However, using these accounts to derive some meaningful and actionable indicators such as PTB Ratio of 14.22 or Days Sales Outstanding of 90.0 will help investors to properly organize and evaluate Danimer Scientific financial condition quickly.

Quick Ratio Current Ratio

Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Danimer Scientific. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population.

To learn how to invest in Danimer Stock, please use our How to Invest in Danimer Scientific guide.

About Danimer Financial Ratios Analysis

Danimer ScientificFinancial ratios are relationships based on a company's financial information. They can serve as useful tools to evaluate Danimer Scientific investment potential. Financial ratio analysis can also be defined as the process of presenting financial ratios, which are mathematical indicators calculated by comparing key financial information appearing on Danimer financial statements. Financial ratios are useful tools that help investors analyze and compare relationships between different pieces of financial information across Danimer Scientific history.

Danimer Scientific Financial Ratios Chart

At this time, Danimer Scientific's Book Value Per Share is relatively stable compared to the past year. As of 11/29/2024, Stock Based Compensation To Revenue is likely to grow to 1.26, while PTB Ratio is likely to drop 14.22.

Price To Sales Ratio Ptb Ratio Days Sales Outstanding Book Value Per Share

Add Fundamental

Price To Sales Ratio

Price to Sales Ratio is figured by comparing Danimer Scientific stock price to its revenues. An advantage to using Price to Sales ratio is that it is based on Danimer Scientific sales, a figure that is much harder to manipulate than other Danimer Scientific multiples. Because sales tend to be more stable P/S ratio can be a good tool for screening cyclical companies fluctuating earnings patterns. A valuation ratio that compares a company's stock price to its revenues, calculated by dividing the company's market cap by its total sales or revenue over a 12-month period.

Ptb Ratio

Price-to-Book ratio, a financial valuation metric used to compare a company's current market price to its book value. It provides insight into the value that market participants place on the company's equity relative to its net asset value.

Book Value Per Share

The ratio of equity available to common shareholders divided by the number of outstanding shares. This measure represents the value per share of a company according to its financial statements.

Most ratios from Danimer Scientific's fundamentals are interrelated and interconnected. However, analyzing fundamentals ratios one by one will only give a small insight into Danimer Scientific current financial condition. On the other hand, looking into the entire matrix of fundamentals ratios, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Danimer Scientific. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population.

To learn how to invest in Danimer Stock, please use our How to Invest in Danimer Scientific guide.At this time, Danimer Scientific's Book Value Per Share is relatively stable compared to the past year. As of 11/29/2024, Stock Based Compensation To Revenue is likely to grow to 1.26, while PTB Ratio is likely to drop 14.22.

	2021	2022	2023	2024 (projected)
Days Sales Outstanding	152.59	166.74	147.65	90.0
PTB Ratio	63.41	19.17	14.97	14.22

Days Sales Outstanding Ptb Ratio

Danimer Scientific fundamentals Correlations

	Price To Sales Ratio	Ptb Ratio	Days Sales Outstanding	Book Value Per Share	Free Cash Flow Yield	Operating Cash Flow Per Share	Capex To Depreciation	Pb Ratio	Ev To Sales	Free Cash Flow Per Share	Roic	Inventory Turnover	Net Income Per Share	Days Of Inventory On Hand	Payables Turnover	Capex To Revenue	Cash Per Share	Pocfratio	Interest Coverage	Capex To Operating Cash Flow	Pfcf Ratio	Days Payables Outstanding	Income Quality	Roe	Ev To Operating Cash Flow	Pe Ratio
Price To Sales Ratio		0.31	-0.13	-0.35	0.21	-0.26	0.5	0.31	1.0	0.37	-0.03	-0.52	-0.03	0.47	-0.63	0.27	0.63	-0.73	-0.24	-0.45	-0.91	0.63	-0.16	-0.01	-0.73	-0.78
Ptb Ratio	0.31		-0.37	-0.59	0.27	0.05	0.38	1.0	0.31	0.14	-0.1	-0.28	-0.06	0.19	-0.52	0.11	-0.2	-0.71	0.03	-0.69	-0.25	0.68	-0.44	-0.68	-0.71	-0.39
Days Sales Outstanding	-0.13	-0.37		-0.38	-0.77	-0.79	0.43	-0.37	-0.13	-0.33	-0.69	-0.6	-0.67	0.69	-0.32	0.75	-0.29	-0.03	-0.47	-0.26	0.44	0.21	-0.42	-0.17	-0.04	-0.27
Book Value Per Share	-0.35	-0.59	-0.38		0.5	0.72	-0.52	-0.59	-0.35	-0.33	0.81	0.87	0.81	-0.78	0.82	-0.57	0.47	0.86	0.15	0.97	0.06	-0.72	0.96	0.9	0.87	0.82
Free Cash Flow Yield	0.21	0.27	-0.77	0.5		0.75	-0.11	0.27	0.21	-0.02	0.9	0.61	0.89	-0.66	0.35	-0.57	0.62	0.13	-0.03	0.36	-0.43	-0.08	0.66	0.44	0.14	0.33
Operating Cash Flow Per Share	-0.26	0.05	-0.79	0.72	0.75		-0.62	0.05	-0.26	-0.04	0.87	0.91	0.87	-0.88	0.75	-0.82	0.26	0.51	0.52	0.67	-0.12	-0.54	0.75	0.49	0.53	0.73
Capex To Depreciation	0.5	0.38	0.43	-0.52	-0.11	-0.62		0.38	0.51	-0.4	-0.35	-0.72	-0.29	0.74	-0.82	0.87	0.2	-0.6	-0.81	-0.65	-0.16	0.91	-0.36	-0.29	-0.6	-0.61
Pb Ratio	0.31	1.0	-0.37	-0.59	0.27	0.05	0.38		0.31	0.14	-0.1	-0.28	-0.06	0.19	-0.52	0.11	-0.2	-0.71	0.03	-0.69	-0.25	0.68	-0.44	-0.68	-0.71	-0.39
Ev To Sales	1.0	0.31	-0.13	-0.35	0.21	-0.26	0.51	0.31		0.37	-0.03	-0.53	-0.03	0.48	-0.63	0.27	0.62	-0.73	-0.24	-0.45	-0.91	0.63	-0.17	-0.02	-0.73	-0.78
Free Cash Flow Per Share	0.37	0.14	-0.33	-0.33	-0.02	-0.04	-0.4	0.14	0.37		-0.16	-0.14	-0.26	-0.03	-0.08	-0.43	-0.08	-0.42	0.51	-0.25	-0.46	-0.12	-0.36	-0.3	-0.42	-0.44
Roic	-0.03	-0.1	-0.69	0.81	0.9	0.87	-0.35	-0.1	-0.03	-0.16		0.83	0.99	-0.81	0.66	-0.67	0.64	0.51	0.1	0.72	-0.27	-0.41	0.91	0.74	0.52	0.63
Inventory Turnover	-0.52	-0.28	-0.6	0.87	0.61	0.91	-0.72	-0.28	-0.53	-0.14	0.83		0.81	-0.97	0.92	-0.83	0.17	0.8	0.4	0.86	0.18	-0.78	0.82	0.61	0.8	0.91
Net Income Per Share	-0.03	-0.06	-0.67	0.81	0.89	0.87	-0.29	-0.06	-0.03	-0.26	0.99	0.81		-0.76	0.62	-0.6	0.63	0.5	0.09	0.7	-0.26	-0.35	0.92	0.73	0.51	0.64
Days Of Inventory On Hand	0.47	0.19	0.69	-0.78	-0.66	-0.88	0.74	0.19	0.48	-0.03	-0.81	-0.97	-0.76		-0.87	0.9	-0.13	-0.69	-0.41	-0.77	-0.13	0.76	-0.73	-0.5	-0.7	-0.82
Payables Turnover	-0.63	-0.52	-0.32	0.82	0.35	0.75	-0.82	-0.52	-0.63	-0.08	0.66	0.92	0.62	-0.87		-0.78	0.05	0.89	0.44	0.91	0.31	-0.92	0.74	0.62	0.89	0.9
Capex To Revenue	0.27	0.11	0.75	-0.57	-0.57	-0.82	0.87	0.11	0.27	-0.43	-0.67	-0.83	-0.6	0.9	-0.78		-0.09	-0.46	-0.66	-0.61	0.1	0.75	-0.52	-0.35	-0.47	-0.58
Cash Per Share	0.63	-0.2	-0.29	0.47	0.62	0.26	0.2	-0.2	0.62	-0.08	0.64	0.17	0.63	-0.13	0.05	-0.09		0.03	-0.33	0.34	-0.71	0.09	0.64	0.73	0.04	-0.05
Pocfratio	-0.73	-0.71	-0.03	0.86	0.13	0.51	-0.6	-0.71	-0.73	-0.42	0.51	0.8	0.5	-0.69	0.89	-0.46	0.03		0.16	0.92	0.52	-0.85	0.73	0.69	1.0	0.92
Interest Coverage	-0.24	0.03	-0.47	0.15	-0.03	0.52	-0.81	0.03	-0.24	0.51	0.1	0.4	0.09	-0.41	0.44	-0.66	-0.33	0.16		0.25	-0.08	-0.53	0.04	-0.07	0.17	0.28
Capex To Operating Cash Flow	-0.45	-0.69	-0.26	0.97	0.36	0.67	-0.65	-0.69	-0.45	-0.25	0.72	0.86	0.7	-0.77	0.91	-0.61	0.34	0.92	0.25		0.16	-0.84	0.9	0.87	0.93	0.85
Pfcf Ratio	-0.91	-0.25	0.44	0.06	-0.43	-0.12	-0.16	-0.25	-0.91	-0.46	-0.27	0.18	-0.26	-0.13	0.31	0.1	-0.71	0.52	-0.08	0.16		-0.34	-0.11	-0.19	0.51	0.51
Days Payables Outstanding	0.63	0.68	0.21	-0.72	-0.08	-0.54	0.91	0.68	0.63	-0.12	-0.41	-0.78	-0.35	0.76	-0.92	0.75	0.09	-0.85	-0.53	-0.84	-0.34		-0.55	-0.53	-0.85	-0.76
Income Quality	-0.16	-0.44	-0.42	0.96	0.66	0.75	-0.36	-0.44	-0.17	-0.36	0.91	0.82	0.92	-0.73	0.74	-0.52	0.64	0.73	0.04	0.9	-0.11	-0.55		0.92	0.74	0.73
Roe	-0.01	-0.68	-0.17	0.9	0.44	0.49	-0.29	-0.68	-0.02	-0.3	0.74	0.61	0.73	-0.5	0.62	-0.35	0.73	0.69	-0.07	0.87	-0.19	-0.53	0.92		0.7	0.55
Ev To Operating Cash Flow	-0.73	-0.71	-0.04	0.87	0.14	0.53	-0.6	-0.71	-0.73	-0.42	0.52	0.8	0.51	-0.7	0.89	-0.47	0.04	1.0	0.17	0.93	0.51	-0.85	0.74	0.7		0.93
Pe Ratio	-0.78	-0.39	-0.27	0.82	0.33	0.73	-0.61	-0.39	-0.78	-0.44	0.63	0.91	0.64	-0.82	0.9	-0.58	-0.05	0.92	0.28	0.85	0.51	-0.76	0.73	0.55	0.93

Click cells to compare fundamentals

Danimer Scientific Account Relationship Matchups

Danimer Scientific fundamentals Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Price To Sales Ratio	302.78	1.7K	539.94	136.01	89.15	84.69
Ptb Ratio	590.81	181.13	63.41	19.17	14.97	14.22
Days Sales Outstanding	62.33	62.24	152.59	166.74	147.65	90.0
Book Value Per Share	0.65	5.19	5.37	3.74	2.73	4.92
Free Cash Flow Yield	(0.003904)	(6.55E-4)	(0.00783)	(0.0313)	(0.018)	(0.0189)
Operating Cash Flow Per Share	(0.0659)	(0.16)	(0.68)	(0.61)	(0.46)	(0.49)
Stock Based Compensation To Revenue	0.16	0.077	0.94	1.07	1.2	1.26
Capex To Depreciation	8.99	7.47	17.44	8.19	0.95	0.91
Pb Ratio	590.81	181.13	63.41	19.17	14.97	14.22
Ev To Sales	305.78	1.7K	539.96	140.73	96.62	91.79
Free Cash Flow Per Share	(1.51)	(0.62)	(2.67)	(2.24)	(0.73)	(0.77)
Roic	(0.13)	(0.0376)	(0.11)	(0.28)	(0.19)	(0.2)
Inventory Turnover	3.02	2.63	2.35	1.94	2.91	3.22
Net Income Per Share	(0.77)	(0.18)	(0.65)	(1.78)	(1.52)	(1.6)
Days Of Inventory On Hand	120.96	138.79	155.0	187.82	125.25	107.29
Payables Turnover	2.62	3.38	2.78	4.25	13.92	8.04
Capex To Revenue	1.13	0.81	3.16	3.09	0.59	0.56
Cash Per Share	0.25	4.47	3.08	0.62	0.58	0.55
Pocfratio	(5.9K)	(5.8K)	(503.8)	(117.06)	(88.05)	(92.45)
Capex To Operating Cash Flow	(21.85)	(2.77)	(2.94)	(2.66)	(0.59)	(0.62)
Pfcf Ratio	(256.15)	(1.5K)	(127.71)	(31.98)	(55.53)	(58.3)
Days Payables Outstanding	139.56	107.95	131.14	85.91	26.23	24.92
Income Quality	0.0857	1.1	1.05	0.34	0.3	0.29
Roe	(1.18)	(0.0341)	(0.12)	(0.48)	(0.56)	(0.59)
Ev To Operating Cash Flow	(5.9K)	(5.7K)	(503.82)	(121.12)	(95.43)	(100.21)
Pe Ratio	(501.86)	(5.3K)	(527.74)	(40.27)	(26.77)	(28.11)
Return On Tangible Assets	(0.14)	(0.0275)	(0.0869)	(0.28)	(0.25)	(0.26)
Ev To Free Cash Flow	(258.68)	(1.5K)	(127.72)	(33.09)	(60.18)	(63.19)
Earnings Yield	(0.001993)	(1.88E-4)	(0.001895)	(0.0248)	(0.0374)	(0.0355)
Net Debt To E B I T D A	(14.04)	28.53	(0.009508)	(2.43)	(3.62)	(3.44)
Current Ratio	0.56	7.97	7.83	4.95	6.87	3.94
Tangible Book Value Per Share	0.57	5.17	3.79	2.93	1.96	1.86
Graham Number	3.36	4.55	8.84	12.22	9.67	5.66
Shareholders Equity Per Share	0.65	5.19	5.37	3.74	2.73	4.92
Debt To Equity	5.01	0.14	0.53	0.77	1.39	1.84
Capex Per Share	1.44	0.45	1.99	1.63	0.27	0.26

Pair Trading with Danimer Scientific

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Danimer Scientific position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Danimer Scientific will appreciate offsetting losses from the drop in the long position's value.

Moving together with Danimer Stock

0.71

FutureFuel Corp

Pair Corr

Moving against Danimer Stock

0.79	WTTR	Select Energy Services	Pair Corr
0.78	WDFC	WD 40 Company	Pair Corr
0.76	ECVT	Ecovyst Potential Growth	Pair Corr
0.65	ESI	Element Solutions	Pair Corr
0.43	ALB	Albemarle Corp	Pair Corr

The ability to find closely correlated positions to Danimer Scientific could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Danimer Scientific when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Danimer Scientific - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Danimer Scientific to buy it.

The correlation of Danimer Scientific is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Danimer Scientific moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Danimer Scientific moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

Correlation analysis and pair trading evaluation for Danimer Scientific can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.

Pair Correlation Correlation Matching

Additional Tools for Danimer Stock Analysis

When running Danimer Scientific's price analysis, check to measure Danimer Scientific's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Danimer Scientific is operating at the current time. Most of Danimer Scientific's value examination focuses on studying past and present price action to predict the probability of Danimer Scientific's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Danimer Scientific's price. Additionally, you may evaluate how the addition of Danimer Scientific to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Price To Sales Ratio	Dividend Yield
Ptb Ratio	Days Sales Outstanding
Book Value Per Share	Free Cash Flow Yield
Invested Capital	Operating Cash Flow Per Share
Average Payables	Stock Based Compensation To Revenue
Capex To Depreciation	Pb Ratio
Ev To Sales	Free Cash Flow Per Share
Roic	Inventory Turnover
Net Income Per Share	Days Of Inventory On Hand
Payables Turnover	Sales General And Administrative To Revenue
Average Inventory	Research And Ddevelopement To Revenue
Capex To Revenue	Cash Per Share
Pocfratio	Interest Coverage
Payout Ratio	Capex To Operating Cash Flow
Pfcf Ratio	Days Payables Outstanding
Net Current Asset Value	Income Quality
Roe	Tangible Asset Value
Ev To Operating Cash Flow	Pe Ratio
Return On Tangible Assets	Ev To Free Cash Flow
Earnings Yield	Intangibles To Total Assets
Net Debt To E B I T D A	Current Ratio
Tangible Book Value Per Share	Receivables Turnover
Graham Number	Shareholders Equity Per Share
Debt To Equity	Capex Per Share
Graham Net Net	Average Receivables
Revenue Per Share	Interest Debt Per Share
Debt To Assets	Enterprise Value Over E B I T D A
Short Term Coverage Ratios	Price Earnings Ratio
Operating Cycle	Price Book Value Ratio
Price Earnings To Growth Ratio	Days Of Payables Outstanding
Dividend Payout Ratio	Price To Operating Cash Flows Ratio
Price To Free Cash Flows Ratio	Pretax Profit Margin
Ebt Per Ebit	Operating Profit Margin
Effective Tax Rate	Company Equity Multiplier
Long Term Debt To Capitalization	Total Debt To Capitalization
Return On Capital Employed	Debt Equity Ratio
Ebit Per Revenue	Quick Ratio
Dividend Paid And Capex Coverage Ratio	Net Income Per E B T
Cash Ratio	Cash Conversion Cycle
Operating Cash Flow Sales Ratio	Days Of Inventory Outstanding
Days Of Sales Outstanding	Free Cash Flow Operating Cash Flow Ratio
Cash Flow Coverage Ratios	Price To Book Ratio
Fixed Asset Turnover	Capital Expenditure Coverage Ratio
Price Cash Flow Ratio	Enterprise Value Multiple
Debt Ratio	Cash Flow To Debt Ratio
Price Sales Ratio	Return On Assets
Asset Turnover	Net Profit Margin
Gross Profit Margin	Price Fair Value
Return On Equity

Danimer Historical Financial Ratios

About Danimer Financial Ratios Analysis

Danimer Scientific Financial Ratios Chart

Price To Sales Ratio

Ptb Ratio

Book Value Per Share

Danimer Scientific fundamentals Correlations

Danimer Scientific Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Danimer Scientific fundamentals Accounts

Pair Trading with Danimer Scientific

Moving together with Danimer Stock

Moving against Danimer Stock

Additional Tools for Danimer Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Ev To Sales	+ 1.0	Price To Sales Ratio
Pb Ratio	+ 1.0	Ptb Ratio
Ev To Operating Cash Flow	+ 1.0	Pocfratio
Net Income Per Share	+ 0.99	Roic
Capex To Operating Cash Flow	+ 0.97	Book Value Per Share
Income Quality	+ 0.96	Book Value Per Share

Days Of Inventory On Hand	- 0.97	Inventory Turnover
Days Payables Outstanding	- 0.92	Payables Turnover
Pfcf Ratio	- 0.91	Ev To Sales
Pfcf Ratio	- 0.91	Price To Sales Ratio
Days Of Inventory On Hand	- 0.88	Operating Cash Flow Per Share
Payables Turnover	- 0.87	Days Of Inventory On Hand